Comerica Bank
CUE icon

Comerica Bank’s Cue Biopharma CUE Stock Holding History

Comerica Bank’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-86
Closed -$3.22K – 3692
2024
Q2 		$3.22K Buy
86
+18
+26% +$890 ﹤0.01% 3383
2024
Q1 		$3.83K Buy
68
+19
+39% +$1.34K ﹤0.01% 3389
2023
Q4 		$3.89K Buy
+49
New +$3.5K ﹤0.01% 3377

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
GLA
Good Life Advisors Reading, Pennsylvania $1.6B AUM 15.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Comerica Bank's CUE Position: Q3 2024 in Review

Comerica Bank sold out of Cue Biopharma (CUE) in Q3 2024, closing a stake of 86 shares — an estimated $3.22K sold.

Comerica Bank first reported a position in CUE in Q4 2023 and held it in 3 quarters. The position peaked at $3.89K in Q4 2023. 50 funds tracked by Wall St. Rank hold CUE as of Q3 2024.

  • Comerica Bank reported no remaining Cue Biopharma position as of Q3 2024 after selling out during the quarter.
  • Comerica Bank sold 86 Cue Biopharma shares in Q3 2024, an estimated $3.22K.
  • Comerica Bank first reported a position in Cue Biopharma in Q4 2023 and held it in 3 quarters.
  • Comerica Bank's Cue Biopharma position peaked at $3.89K in Q4 2023.
  • 50 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2024.

Based on Comerica Bank's 13F filing for Q3 2024, filed 14 Nov 2024.